Home
Clinigen

Clinigen Market Share Analysis for June 2026

Burlington Labs is a toxicology laboratory offering fast and reliable drug testing for doctors, counselors, and other providers in substance abuse treatment programs. Our focus is on supporting those in recovery from drug addiction and alcohol addiction.

Health > Addictions

Domainclinigen.com

Year Founded2010

Employees1001 - 5000

Annual Revenue--

Clinigen

Clinigen (including company regionals)

clinigen.com

See more website traffic and engagement information

Total visits to Clinigen's top domains

Understand Clinigen market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Clinigen's top domains

Analyze Clinigen engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Clinigen's top domains

See how Clinigen keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Clinigen top competitors by domain

Top similar sites in June 2026, ranked by their affinity

drugabuse.comCompany NameDrugAbuseEmployees51 - 200HQUnited States, California, Los AltosAnnual revenue$10M - $15MTotal visits131.9KHealth > Health - Other

Top technologies used by Clinigen

These are the website technologies, by industry, used by Clinigen top domains

Conversion & Analytics (1)

Google Analytics

Email Services (1)

G Suite

News & Signals from Clinigen

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsClinigen Group partners with Tepsivo Oy.Clinigen, a global specialist pharmaceutical services company, entered a strategic partnership with Tepsivo, a digital Pharmacovigilance (PV) services provider.

NewsSanthera Pharmaceuticals AG partnered with Clinigen Group on Jan 6th '25.Pratteln, Switzerland, January 6, 2025 - Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE(R) (vamorolone) in countries where the product is not otherwise commercially available.